Consistent with this notion, CD22-deficient mice show signs of B cell hyperactivation and can develop autoimmune diseases, particularly when in combination with deficiency of another B-cell Siglec, Siglec-G [19, 20]. This evidence concerns the gene CD22 and autoimmune disease.